[1]
Dutta, S., Kaur, R., Bhardwaj, P., Deora, S., Singh, K., Ambwani, S., Charan, J., Abubakar, A.R., Jahan, I., Lugova, H., Islam, S. and Haque, M. 2021. Hydroxychloroquine as Therapeutic Option in COVID-19: Analysis of Suspected Cardiovascular Adverse Drug Events Reported in the VigiBase. Bangladesh Journal of Medical Science. 20, 4 (Jun. 2021), 897–910. DOI:https://doi.org/10.3329/bjms.v20i4.54150.